These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17407206)

  • 1. Focus on: New Zealand.
    Biotechnol J; 2007 Apr; 2(4):418-20. PubMed ID: 17407206
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotechnology round the world: focus on: Spain.
    Biotechnol J; 2008 Jan; 3(1):28-30. PubMed ID: 18200495
    [No Abstract]   [Full Text] [Related]  

  • 3. Focus on Switzerland.
    Biotechnol J; 2007 Aug; 2(8):931-3. PubMed ID: 17680715
    [No Abstract]   [Full Text] [Related]  

  • 4. Public biotechnology 2002--the numbers.
    Lähteenmäki R; DeFrancesco L
    Nat Biotechnol; 2003 Jun; 21(6):607-12. PubMed ID: 12776143
    [No Abstract]   [Full Text] [Related]  

  • 5. Tech transfer revs up.
    Lawrence S
    Nat Biotechnol; 2006 Jan; 24(1):13. PubMed ID: 16404380
    [No Abstract]   [Full Text] [Related]  

  • 6. Decentralization key to ScanBalt.
    Frank P
    Nat Biotechnol; 2005 Oct; 23(10):1211. PubMed ID: 16211052
    [No Abstract]   [Full Text] [Related]  

  • 7. Five attributes of a successful manager in a research organization.
    Wong GH
    Nat Biotechnol; 2006 Sep; 24(9):1171-4. PubMed ID: 16964236
    [No Abstract]   [Full Text] [Related]  

  • 8. MDT's five-minute interview.
    Borghs G
    Med Device Technol; 2009 Oct; 20(6):6. PubMed ID: 20302134
    [No Abstract]   [Full Text] [Related]  

  • 9. Chinese biotech: the need for innovation and higher standards.
    Wong GH
    Nat Biotechnol; 2006 Feb; 24(2):221-2. PubMed ID: 16465169
    [No Abstract]   [Full Text] [Related]  

  • 10. University spin-offs: opportunity or challenge?
    Peng X
    Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
    [No Abstract]   [Full Text] [Related]  

  • 11. Public biotechnology 2003-the numbers.
    Lähteenmäki R; Baker M
    Nat Biotechnol; 2004 Jun; 22(6):665-70. PubMed ID: 15175683
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical device research.
    Boyle J; Maeder A; Bell J; John S; Scott R
    Expert Rev Med Devices; 2005 Jan; 2(1):41-5. PubMed ID: 16293027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access and openness in biotechnology research collaborations between universities and industry.
    Egelie KJ; Lie HT; Grimpe C; Sørheim R
    Nat Biotechnol; 2019 Dec; 37(12):1413-1419. PubMed ID: 31796918
    [No Abstract]   [Full Text] [Related]  

  • 14. Focus on: Sweden.
    Biotechnol J; 2007 May; 2(5):528-30. PubMed ID: 17479974
    [No Abstract]   [Full Text] [Related]  

  • 15. Syngenta ends plant-research deal with Berkeley.
    Dalton R
    Nature; 2003 Nov; 426(6964):216. PubMed ID: 14628007
    [No Abstract]   [Full Text] [Related]  

  • 16. Opportunities in New Zealand for biotechnology process development and contract research. The Biotechnology Group of DSIR Industrial Development, New Zealand.
    Kennedy MJ; Davies J
    Aust J Biotechnol; 1991 Apr; 5(2):67-72. PubMed ID: 1367322
    [No Abstract]   [Full Text] [Related]  

  • 17. A firm shift.
    Nature; 2017 Dec; 552(7683):S6-S7. PubMed ID: 29219987
    [No Abstract]   [Full Text] [Related]  

  • 18. TBA's structure and focus confuse investors. Thermo BioAnalysis.
    Alper J
    Nat Biotechnol; 1999 Jan; 17(1):13-4. PubMed ID: 9920253
    [No Abstract]   [Full Text] [Related]  

  • 19. The German MedTech industry in 2007.
    Schmitt JM; Beeres M
    Med Device Technol; 2007; 18(7):56. PubMed ID: 18075138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public biotech 99: the numbers.
    Lähteenmäki R; Hodgson J
    Nat Biotechnol; 2000 May; 18(5):499-503. PubMed ID: 10802615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.